Study to compare minoxidil lotion and minoxidil plus platelet rich plasma therapy in male pattern hairloss
Phase 4
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2024/07/070098
- Lead Sponsor
- ERA S LUCKNOW MEDICAL COLLEGE AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All consenting male patients in the age group of 20–50 years with AGA stage II–VI Norwood-Hamilton classification visiting in dermatology OPD.
Exclusion Criteria
1.Patients who have taken any form of treatment in past three months.
2.Patient with a history of hypersensitivity to minoxidil.
3.Patient with a history of bleeding disorders, on anticoagulants medications (aspirin, warfarin, heparin) and and with positive viral markers.
4.Patients with active infection at local site, nonpatterned alopecia, keloidal tendency, history of psoriasis, lichen planus and vitiligo.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method